KARLSRUHE, Germany--(BUSINESS WIRE)--Jul. 1, 2009--
Bruker BioSpin today announces its first order for an ELEXSYS™
E780 system, the world’s first commercial mm-wave 263
Gigahertz (GHz) EPR spectrometer. This unique new system represents a
first step for the Bruker EPR division into quasi-optical microwave
technology. The E780 incorporates a unique superconducting
magnet that can be ramped up to 12 Tesla, and when combined with new EPR
probe technology for optimum sensitivity, can measure even large samples
up to 5 mm. Based on the well-proven Bruker ELEXSYS
concept, the E780 provides multiple turn-key operation
modes including CW- and Pulse-EPR, as well as ENDOR and ELDOR, thus
enabling leading research groups for the first time to use 263 GHz EPR
technology routinely.
The first E780 system is expected to be installed at the
Helmholtz-Zentrum in Berlin in late 2009 for pioneering new EPR
applications in solar energy and photovoltaic research. The total E780
order amount is more than $2.2 million, and was supported by the recent
German stimulus package “Konjunkturpaket”. It represents the start of a
new research collaboration project between Bruker and the
Helmholtz-Zentrum on EPR probe development for electrical detection.
The ELEXSYS E780 is equipped with a quasi-optical front
end featuring reflection and induction detection with safe and robust
operation. The front-end is interfaced to a single mode resonator for
highest sensitivity, and to a non-resonant probe featuring a larger
diameter for samples up to 5 mm, both of which allow low temperature
measurements down to 4 Kelvin. As with all other ELEXSYS
systems, the E780 is driven by the proprietary
Intermediate Frequency (IF) concept for optimum phase stability and
pulse precision, and runs the Bruker software package Xepr,
for routine and assisted expert workflows.
“With the development of the 263 GHz spectrometer Bruker once again sets
a milestone in EPR technology, by delivering the world’s highest
commercial EPR frequency,” commented Dr. Dieter Schmalbein, Managing
Director of Bruker BioSpin. “This novel and unique commercial E780 system
greatly expands the range of applications in very high-field EPR.”
“With this new instrument we will be able to identify important details
about the structure of defects in thin-film silicon solar cells,” stated
Dr. Klaus Lips from Helmholtz-Zentrum Berlin, the coordinator of the
German research network EPR-Solar. “I am very grateful to the Federal
Ministry of Research and Education (BMBF) for their financial support.
The unique E780 spectrometer will strengthen our worldwide
leadership in EPR research in the photovoltaic community.”
For further information on ELEXSYS E780, please visit www.bruker-biospin.com/e780
For information about Bruker BioSpin and Bruker Corporation (NASDAQ:
BRKR), visit www.bruker.com
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5998539&lang=en
Source: Bruker BioSpin
Bruker BioSpin
Dr. Thorsten Thiel, +49 (721) 5161 – 6517
Director
of Marketing Communications
thorsten.thiel@bruker.de